These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16462674)

  • 1. [Antiretroviral drugs in severe acute respiratory syndrome].
    Yazdanpanah Y; Guéry B
    Presse Med; 2006 Jan; 35(1 Pt 2):105-7. PubMed ID: 16462674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of baseline protease inhibitor resistance on the efficacy of darunavir/ritonavir or lopinavir/ritonavir in the TITAN trial.
    De Meyer S; Hill A; Picchio G; DeMasi R; De Paepe E; de Béthune MP
    J Acquir Immune Defic Syndr; 2008 Dec; 49(5):563-4. PubMed ID: 19202459
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic treatment of SARS: current knowledge and recommendations.
    Tai DY
    Ann Acad Med Singap; 2007 Jun; 36(6):438-43. PubMed ID: 17597972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.
    Chu CM; Cheng VC; Hung IF; Wong MM; Chan KH; Chan KS; Kao RY; Poon LL; Wong CL; Guan Y; Peiris JS; Yuen KY;
    Thorax; 2004 Mar; 59(3):252-6. PubMed ID: 14985565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV].
    Shchukina VN; Loginova SIa; Borisevich SV; Bondarev VP
    Antibiot Khimioter; 2011; 56(7-8):42-6. PubMed ID: 22359870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancements in the battle against severe acute respiratory syndrome.
    Hui DS; Wong GW
    Expert Opin Pharmacother; 2004 Aug; 5(8):1687-93. PubMed ID: 15264983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.
    Delfraissy JF; Flandre P; Delaugerre C; Ghosn J; Horban A; Girard PM; Norton M; Rouzioux C; Taburet AM; Cohen-Codar I; Van PN; Chauvin JP
    AIDS; 2008 Jan; 22(3):385-93. PubMed ID: 18195565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.
    Yao TT; Qian JD; Zhu WY; Wang Y; Wang GQ
    J Med Virol; 2020 Jun; 92(6):556-563. PubMed ID: 32104907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lopinavir/ritonavir: a review of its use in the management of HIV infection.
    Cvetkovic RS; Goa KL
    Drugs; 2003; 63(8):769-802. PubMed ID: 12662125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.
    Walmsley S; Bernstein B; King M; Arribas J; Beall G; Ruane P; Johnson M; Johnson D; Lalonde R; Japour A; Brun S; Sun E;
    N Engl J Med; 2002 Jun; 346(26):2039-46. PubMed ID: 12087139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations at codons 54 and 82 of HIV protease predict virological response of HIV-infected children on salvage lopinavir/ritonavir therapy.
    Luis Jiménez J; Resino S; Martinez-Colom A; Bellón JM; Angeles Muñoz-Fernández M;
    J Antimicrob Chemother; 2005 Dec; 56(6):1081-6. PubMed ID: 16195257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consideration of highly active antiretroviral therapy in the prevention and treatment of severe acute respiratory syndrome.
    Chen XP; Cao Y
    Clin Infect Dis; 2004 Apr; 38(7):1030-2. PubMed ID: 15034838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent patents on treatment of severe acute respiratory syndrome (SARS).
    Zhai S; Liu W; Yan B
    Recent Pat Antiinfect Drug Discov; 2007 Jan; 2(1):1-10. PubMed ID: 18221160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with lopinavir/ritonavir in heavily pretreated subjects failing multiple antiretroviral regimens in clinical practice.
    Romano L; Peduzzi C; Venturi G; Di Pietro M; Carli T; Corsi P; Gonnelli A; Valensin PE; Zazzi M
    J Acquir Immune Defic Syndr; 2002 Aug; 30(5):533-5. PubMed ID: 12154345
    [No Abstract]   [Full Text] [Related]  

  • 17. Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression.
    Chan-Tack KM; Edozien A
    J Acquir Immune Defic Syndr; 2006 Apr; 41(4):531-2. PubMed ID: 16652066
    [No Abstract]   [Full Text] [Related]  

  • 18. Safety and antiviral activity of lopinavir/ritonavir-based therapy in human immunodeficiency virus type 1 (HIV-1) infection.
    Kaplan SS; Hicks CB
    J Antimicrob Chemother; 2005 Aug; 56(2):273-6. PubMed ID: 15994247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in rates of diarrhea in patients with human immunodeficiency virus receiving lopinavir-ritonavir or nelfinavir.
    Guest JL; Ruffin C; Tschampa JM; DeSilva KE; Rimland D
    Pharmacotherapy; 2004 Jun; 24(6):727-35. PubMed ID: 15222662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of lopinavir in individuals experiencing protease inhibitor failure.
    Gilleece YC; Qazi NA; Morlese JF; Mandalia S; Gazzard BG; Pozniak AL; Nelson MR
    J Acquir Immune Defic Syndr; 2003 Feb; 32(2):238-40. PubMed ID: 12571536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.